Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total Bond Market
BND
|
+$1.02B |
| 2 |
Canadian Natural Resources
CNQ
|
+$958M |
| 3 |
iShares Core US Aggregate Bond ETF
AGG
|
+$896M |
| 4 |
Vanguard S&P 500 ETF
VOO
|
+$861M |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$756M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.62B |
| 2 |
Amgen
AMGN
|
+$1.68B |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$1.18B |
| 4 |
Visa
V
|
+$1.05B |
| 5 |
Invesco QQQ Trust
QQQ
|
+$1B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.79% |
| 2 | Healthcare | 9.32% |
| 3 | Financials | 8.97% |
| 4 | Consumer Discretionary | 7.33% |
| 5 | Industrials | 5.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1426
Natera
NTRA
$39.7B
| $36.6M | 0.01% |
912,346
+91,258
| +11% | +$3.76M |
|
1427
PUT
Prologis
PLD
$131B
| $36.6M | 0.01% |
325,000
+93,700
| +41% | +$10.4M |
|
|
CNR
1428
Core Natural Resources Inc
CNR
$4.16B
| $36.6M | 0.01% |
562,568
+152,605
| +37% | +$10.3M |
|
|
XYZ
1429
CALL
Block Inc
XYZ
$50.2B
| $36.6M | 0.01% |
581,700
+379,700
| +188% | +$23.4M |
|
1430
Vanguard Russell 1000 Value ETF
VONV
$21B
| $36.6M | 0.01% |
549,022
-233,045
| -30% | -$15.3M |
|
1431
CALL
Invesco Solar ETF
TAN
$1.46B
| $36.5M | 0.01% |
500,000
+75,000
| +18% | +$5.65M |
|
1432
BorgWarner
BWA
$13.9B
| $36.5M | 0.01% |
1,028,948
+143,068
| +16% | +$4.87M |
|
1433
Celanese
CE
$4.58B
| $36.4M | 0.01% |
355,887
+20,127
| +6% | +$2M |
|
1434
PUT
ARK Innovation ETF
ARKK
$6.1B
| $36.3M | 0.01% |
1,161,000
-2,599,400
| -69% | -$92.9M |
|
|
FTCH
1435
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
| $36.2M | 0.01% |
7,657,734
+3,118,172
| +69% | +$21.7M |
|
1436
Federal Realty Investment Trust
FRT
$10.5B
| $36.2M | 0.01% |
357,954
-136,308
| -28% | -$13.8M |
|
1437
Lennar Class B
LEN.B
$20.7B
| $36.1M | 0.01% |
508,136
+7,038
| +1% | +$457K |
|
1438
Valley National Bancorp
VLY
$8.17B
| $36.1M | 0.01% |
3,193,084
+1,820,707
| +133% | +$21.4M |
|
|
SAGE
1439
DELISTED
Sage Therapeutics
SAGE
| $36.1M | 0.01% |
946,116
-165,406
| -15% | -$6.32M |
|
|
DCPH
1440
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $36.1M | 0.01% |
2,200,373
-1,566,480
| -42% | -$25.5M |
|
1441
Braze
BRZE
$2.96B
| $36M | 0.01% |
1,319,271
+1,265,837
| +2,369% | +$35.3M |
|
1442
H.B. Fuller
FUL
$3.17B
| $36M | 0.01% |
502,021
-216,970
| -30% | -$15.7M |
|
1443
Dycom Industries
DY
$12.4B
| $35.9M | 0.01% |
384,047
+52,347
| +16% | +$5.27M |
|
1444
PUT
Rockwell Automation
ROK
$50.2B
| $35.9M | 0.01% |
+139,500
| New | +$35M |
|
1445
First Industrial Realty Trust
FR
$8.5B
| $35.8M | 0.01% |
741,018
-1,528,297
| -67% | -$72.9M |
|
|
NARI
1446
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $35.7M | 0.01% |
561,786
+119,280
| +27% | +$8.65M |
|
1447
SPX Corp
SPXC
$10.9B
| $35.7M | 0.01% |
543,176
+123,168
| +29% | +$8.06M |
|
1448
iShares MSCI ACWI ex US ETF
ACWX
$11.8B
| $35.6M | 0.01% |
782,816
+263,478
| +51% | +$11.6M |
|
|
KNBE
1449
DELISTED
KnowBe4, Inc. Class A Common Stock
KNBE
| $35.6M | 0.01% |
1,435,932
+1,341,288
| +1,417% | +$32.7M |
|
1450
Lamb Weston
LW
$7.33B
| $35.5M | 0.01% |
397,316
-670,417
| -63% | -$57M |
|
Similar funds
Goldman Sachs's Q4 2022 Portfolio in Review
As of Q4 2022, Goldman Sachs held 6,669 positions worth $408B, up 3.1% from $396B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Goldman Sachs withdrew a net $13.2B in Q4 2022, closing 721 positions and reducing 2,588 holdings. Its most notable exit was ChemoCentryx, Inc., an estimated $290M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Goldman Sachs opened a new position in Perfect Corp worth $104M.
- Goldman Sachs's largest Q4 2022 buy was Perfect Corp: 14,518,235 shares worth $104M.
- Goldman Sachs added most to Vanguard Total Bond Market in Q4 2022, an estimated $1.02B increase.
- Goldman Sachs's biggest Q4 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.62B.
- Goldman Sachs fully exited ChemoCentryx, Inc. in Q4 2022, selling an estimated $290M.
- Goldman Sachs's ten largest holdings make up 15% of its $408B portfolio in Q4 2022.
- Goldman Sachs opened 429 new positions and closed 721 in Q4 2022.
- Goldman Sachs's portfolio value rose 3.1% quarter-over-quarter to $408B.
Based on Goldman Sachs's 13F filing for Q4 2022, filed 13 Feb 2023.